Form D · Other Health Care

CO-D Therapeutics, Inc.

Madison, WI · CIK 0001664124

Offering snapshot reported Nov 9, 2018 · SEC filing

Reported sold
$428K
Offering amount: $528K
Investors reported
16
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 31, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$214K$428KJan 22, 2016: $145,000.00Jan 22, 2016Nov 9, 2018: $428,000.00Nov 9, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$145,000 → $428,000
  • Reported investors10 → 16

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 9, 2018Amendment$428,000$283,000vs Jan 22, 201616SEC filing
Jan 22, 2016Initial$145,000No comparison10SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-255775

Source: Form D, filed Nov 9, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
J. Patrick Genn Director
Alex S. Kim Director
Kevin R. Kozak Director, Executive
Glen S. Kwon Director, Executive
Paul V. Radspinner Director
Abdalla A. Saad Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
316 West Washington Avenue Suite 675
Madison, WI, 53703